Melanoma-associated paraneoplastic retinopathy: Case report and review of the literature

British Journal of Dermatology

Volumn 137, Issue 3, 1997, Pages 457-460

  Boeck, K ^a   Hofmann, S ^a   Klopfer, M ^a   Ian, U ^a   Schmidt, T ^a   Engst, R ^a   Thirkill, C E ^b   Ring, J ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACARBAZINE; PREDNISONE;

ADULT; ARTICLE; BLINDNESS; CASE REPORT; ELECTRORETINOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LEUKEMOID REACTION; LYMPH NODE METASTASIS; MALE; MELANOMA; NIGHT BLINDNESS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RETINA BIPOLAR GANGLION CELL; RETINOPATHY;

EID: 0030771305     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03759.x     Document Type: Article

References (19)

1. Wagner RF, Nathanson L. Paraneoplastic syndromes, tumor markers and other unusual features of malignant melanoma. J Am Acad Dermatol 1986; 14: 249-51.
2. Scerri L, Zaki I, Allen BR, Golding P. Dermatomyositis associated with malignant melanoma - case report and review of the literature. Clin Exp Dermatol 1994; 19: 523-5.
3. Ellis DL, Kafka SP, Chow JC et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Tréfat, and multiple acrochordons. N Engl J Med 1987; 17: 1582-7.
4. Andreasson S, Ponjavic V, Ehinger B. Full-field electroretinography in a patient with cutaneous melanoma-associated retinopathy. Acta Ophthalmol 1993; 71: 487-90.
5. Berson EL, Lessell S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 1988; 106: 307-11.
6. Kim RY, Retsas S, Fitzke FW et al. Cutaneous melanoma-associated retinopathy. Ophthalmology 1994; 101: 1837-43.
7. Weinstein JM, Kelman SE, Bresnick GH et al. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma. Ophthalmology 1994; 101: 1236-43.
8. Rush JA. Paraneoplastic retinopathy in malignant melanoma. Am J Ophthalmol 1993; 115: 390-1.
9. Alexander KR, Fishman GA, Peachey NS et al. 'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 1992; 35: 477-83.
10. Milam AH, Saari JC, Jacobson SG et al. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 1993; 34: 91-100.
11. Remulla JFC, Pineda R, Gaudio AR. Cutaneous melanoma-associated retinopathy with retinal periphlebitis. Arch Ophthalmol 1995; 113: 854-5.
12. Thirkill CE, Keltner JL, Tyler NK et al. Antibody reaction with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol 1995; 111: 931-7.
13. Polans AS, Buczylko J, Crabb J et al. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 1991; 112: 981-9.
14. Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol 1987: 105: 372-5.
15. Thirkill CE, Fitzgerald P, Sergott RC et al. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve and cancer cells. N Engl J Med 1989; 321: 1589-94.
16. Buchanan TA, Gardiner TA, Archer DB. An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. Am J Ophthalmol 1984; 97: 277-87.
17. Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration: possible autoimmune disorder. Arch Ophthalmol 1993; 101: 564-9.
18. Kornguth SE, Klein R, Appen R et al. Occurrence of antiretinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 1982; 50: 1289-93.
19. Sawyer RA, Selhorst JB, Zimmerman LE. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 1976; 81: 606-13.